In samples from patients with melanoma or neuroblastoma, the reduction of Reg-1 level has been detected, thus abnormalities in cell cycle progression in these tumors can result from the down-regulation of Reg-119,21. This evidence concerns the gene ZC3H12A and neuroblastoma.